Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease
Paul G. Ayoub(University of California, Los Angeles), Donald B. Kohn(University of California, Los Angeles)
Cited by 7
Related Papers
Gene therapy comes of age
|Science|2018|1.4k
Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference
|Journal of Clinical Immunology|2021|28
Rescue of splicing-mediated intron loss maximizes expression in lentiviral vectors containing the human ubiquitin C promoter
|Nucleic Acids Research|2014|20
Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors
|Frontiers in Virology|2021|5